Lymphoma Partnering in 2007-2012 Examined by CurrentPartnering07 Mar 2012 • by Natalie Aster
Сlose-up CurrentPartnering report “Lymphoma Partnering 2007-2012” offers understanding and access to the lymphoma partnering deals and agreements entered into by the world leading healthcare companies.
The report provides an analysis of lymphoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors lymphoma technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Lymphoma Partnering 2007-2012
Published: February, 2012
Price: US$ 995,00
This data driven report contains over 100 links to online copies of actual lymphoma deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
More information can be found in the report “Lymphoma Partnering 2007-2012” by CurrentPartnering.
To order the report or ask for sample pages contact firstname.lastname@example.org